Dudum Andrew's Form 4 filing
Hims & Hers Health, Inc. (HIMS) · filed Feb 14, 2024
- Accession no.
- 0001773751-24-000012
- Filed
- Feb 14, 2024
- Trade date
- Feb 12-14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.51M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dudum AndrewCIK 0001837796 | Director, Officer (Chief Executive Officer), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Class A Common Stock | MOption exerciseAcquired | +81,541 | $2.43 | +$198,144.63 | 133,194 | Direct | |
| Feb 12, 2024 | Class A Common Stock | SSaleDisposed | −81,541 | $9.98F2 | −$813,779.18 | 51,653 | Direct | |
| Feb 13, 2024 | Class A Common Stock | MOption exerciseAcquired | +97,208 | $2.43 | +$236,215.44 | 148,861 | Direct | |
| Feb 13, 2024 | Class A Common Stock | SSaleDisposed | −97,208 | $9.58F3 | −$931,252.64 | 51,653 | Direct | |
| Feb 14, 2024 | Class A Common Stock | MOption exerciseAcquired | +77,382 | $2.43 | +$188,038.26 | 129,035 | Direct | |
| Feb 14, 2024 | Class A Common Stock | SSaleDisposed | −77,382 | $9.90F4 | −$766,081.8 | 51,653 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2024 | Class A Common Stock | MOption exerciseDisposed | −81,541 | $0.00 | $0 | 2,655,613 | Direct | |
| Feb 13, 2024 | Class A Common Stock | MOption exerciseDisposed | −97,208 | $0.00 | $0 | 2,558,405 | Direct | |
| Feb 14, 2024 | Class A Common Stock | MOption exerciseDisposed | −77,382 | $0.00 | $0 | 2,481,023 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.82 - $10.095. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.15 - $9.79. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $9.71 - $10.005. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.